Researchers at Stanford have found an unexpected solution to a major challenge in brain science—using a common food additive, ...

Organogenesis (NASDAQ:ORGO) stock rallied 17% post-market on Thursday after the company released a Q4 earnings report and guidance that topped Street expectations. The biotech company reported a ...

Assembloids: A Versatile Platform for Human Tissue Modeling. This schematic illustrates the classification of assembloids based on four key assembly strategies—multi-region, multi-lineage, multi ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only mode.

CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported profit of $7.7 million in its fourth quarter. On a per-share basis, the Canton… ...

The Massachusetts-based Organogenesis is developing a biomanufacturing facility at 100 Technology Way in Smithfield, Rhode Island. The company welcomed dignitaries to the new plant on May 20, 2025.

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization ...

Organogenesis (ORGO -0.66%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Welcome, ladies and ...

Organogenesis Holdings Inc. (NASDAQ: ORGO) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Gary S. Gillheeney, Sr. – President and Chief Executive Officer Dave ...